menu
    • menu

    Company profile for Spectral Medical

    NEW Drugs in Dev: 1
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Spectral’s vision is to provide a personalized approach that will enable vastly improve outcomes for patients with septic shock by combining a targeted diagnostic test and therapy. It is widely known that endotoxin is a trigger of sepsis. Spectral has conducted a Phase III clinical trial for its lead product, PMX (Toraymyxin™ PMX-20R), for the treatment of patients with septic shock and endotoxemia (measured by the Compan...
    Spectral’s vision is to provide a personalized approach that will enable vastly improve outcomes for patients with septic shock by combining a targeted diagnostic test and therapy. It is widely known that endotoxin is a trigger of sepsis. Spectral has conducted a Phase III clinical trial for its lead product, PMX (Toraymyxin™ PMX-20R), for the treatment of patients with septic shock and endotoxemia (measured by the Company’s Endotoxin Activity Assay (EAA™)).Spectral strives to exceed the highest ethical, financial and scientific standards in all our operations and activities.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Spectral MedicalCanada Flag
    Country
    Country
    Canada
    Address
    Address
    135 The West Mall, Unit 2, Toronto, ON M9C 1C2, CA
    Telephone
    Telephone
    1.888.426.4264
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://spectraldx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/spectralmedical/about/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/spectralmedical

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Spectral Medical Unveils Q1 2026 Financials And Corporate Update
    Spectral Medical Unveils Q1 2026 Financials And Corporate Update

    08 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/08/3291013/0/en/spectral-medical-announces-first-quarter-2026-financial-results-and-provides-corporate-update.html

    GLOBENEWSWIRE
    08 May 2026
    Share Share
    Spectral Medical Announces Q4 & FY 2025 Results and Corporate
    Spectral Medical Announces Q4 & FY 2025 Results and Corporate

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3262891/0/en/Spectral-Medical-Announces-Fourth-Quarter-and-Fiscal-2025-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    Spectral Medical, Vantive Publish Full Results Of Tigris Trial
    Spectral Medical, Vantive Publish Full Results Of Tigris Trial

    24 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/24/3261056/0/en/Spectral-Medical-and-Vantive-Announce-Publication-of-Complete-Results-from-Spectral-s-Tigris-Trial-in-the-Lancet-Respiratory-Medicine.html

    GLOBENEWSWIRE
    24 Mar 2026
    Share Share
    Spectral Provides Update on PMA Submission Timing for PMX-20R
    Spectral Provides Update on PMA Submission Timing for PMX-20R

    26 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/26/3245465/0/en/Spectral-Medical-Provides-Update-on-PMA-Submission-Timing-for-PMX-20R.html

    GLOBENEWSWIRE
    26 Feb 2026
    Share Share
    Spectral Medical Reveals Q3 2025 Financials & Corporate Update
    Spectral Medical Reveals Q3 2025 Financials & Corporate Update

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183570/0/en/Spectral-Medical-Announces-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Spectral Medical Files Base Shelf Prospectus And Revised AIF
    Spectral Medical Files Base Shelf Prospectus And Revised AIF

    29 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/29/3157929/0/en/Spectral-Medical-Inc-Files-Base-Shelf-Prospectus-and-Revised-AIF.html

    GLOBENEWSWIRE
    29 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search